The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
US-based Bayer subsidiary BlueRock Therapeutics has accelerated bemdaneprocel, its investigational cell therapy candidate for Parkinson’s disease, to Phase III trials after a Phase I study saw ...
It's a case of so far, so good for BlueRock Therapeutics' first clinical trial of Parkinson's disease therapy bemdaneprocel, with no major safety issues reported after a year in patients who ...
DC about to get Bawitdaba. Kid Rock will join Carrie Underwood in performing at Donald Trump’s inaugural celebrations that kick off this weekend. The “We The People” singer, 53, will take ...
In 1831, a volcanic eruption flooded the skies with so much sulfur gas that it cooled the planet by nearly two degrees Fahrenheit, causing all manner of famine, devastation, and social upheaval ...
Jeff Bezos's space company Blue Origin has successfully launched its rocket into orbit on its first test flight. New Glenn - described by Blue Origin as a "giant, reusable rocket" and designed for ...
• Blue Origin, the rocket company founded by Jeff Bezos in 2000, waved off an attempt to launch its first orbital rocket. • The New Glenn rocket was scheduled to launch between 1 a.m. and 4 a ...
Here is your 2025 hard rock + metal album release calendar and all of this week's newest albums! Each week is loaded with new rock and metal releases and keeping track of it all can be pretty ...
Bay­er’s ex­per­i­men­tal Parkin­son’s dis­ease ther­a­py made from stem cells will soon en­ter late-stage stud­ies, mark­ing a key test for re­gen­er­a­tive med­i­cine in ne ...
Credit: Shutterstock / Yuri A US-based Bayer subsidiary BlueRock Therapeutics has accelerated bemdaneprocel, its investigational cell therapy candidate for Parkinson’s disease, to Phase III trials ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...